Pmv Pharmaceuticals Inc (PMVP) — Financial Flexibility Index
Pmv Pharmaceuticals Inc (PMVP) has a Financial Flexibility Index of -1.54x as of September 2025. Free cash flow of $-19.82 Million (operating CF $-19.82 Million minus capex $1.00K) represents -2% of total liabilities ($12.85 Million). Check strategic asset allocation of Pmv Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pmv Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Pmv Pharmaceuticals Inc across 8 annual periods. See Pmv Pharmaceuticals Inc (PMVP) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Pmv Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Pmv Pharmaceuticals Inc. For the full company profile including market capitalisation, see PMVP market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.21x | $-73.55 Million | $-73.58 Million | $11.85 Million | ▼ -86.4% |
| 2024 | -3.33x | $-50.63 Million | $-51.28 Million | $15.21 Million | ▼ -61.1% |
| 2023 | -2.07x | $-54.70 Million | $-55.66 Million | $26.46 Million | ▲ +10.0% |
| 2022 | -2.30x | $-55.78 Million | $-63.76 Million | $24.28 Million | ▼ -16.9% |
| 2021 | -1.97x | $-45.22 Million | $-46.57 Million | $23.01 Million | ▲ +61.3% |
| 2020 | -5.08x | $-32.59 Million | $-32.74 Million | $6.41 Million | ▼ -3917.9% |
| 2019 | -0.13x | $-21.96 Million | $-22.07 Million | $173.51 Million | ▲ +5.8% |
| 2018 | -0.13x | $-14.73 Million | $-15.18 Million | $109.60 Million | — |